American Journal of Cardiology

Journal

Publication Venue For

  • Comparison of Transcatheter Pulmonic Valve Implantation With Surgical Pulmonic Valve Replacement in Adults (from the National Inpatient Survey Dataset). 2019
  • Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Rheumatoid Arthritis (from the Nationwide Inpatient Database).  124:1099-1105. 2019
  • Cardiovascular Health and Disease Among Asian-Americans (from the National Health and Nutrition Examination Survey).  124:270-277. 2019
  • One- to 10-Day Versus 11- to 30-Day All-Cause Readmission and Mortality in Older Patients With Heart Failure.  123:1840-1844. 2019
  • Medication-Taking Behaviors and Perceptions Among Adults With Heart Failure (from the REasons for Geographic And Racial Differences in Stroke Study).  123:1667-1674. 2019
  • Cardiovascular Events and Hospital Deaths Among Patients With Severe Sepsis.  123:1406-1413. 2019
  • Sex Differences in Risk Factors for Incident Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke [REGARDS] Study).  123:1453-1457. 2019
  • Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study).  122:768-774. 2018
  • Relation of Cannabis Use and Atrial Fibrillation Among Patients Hospitalized for Heart Failure.  122:129-134. 2018
  • Usefulness of Proneurotensin to Predict Cardiovascular and All-Cause Mortality in a United States Population (from the Reasons for Geographic and Racial Differences in Stroke Study).  122:26-32. 2018
  • Usefulness of the American Heart Association's Life Simple 7 to Predict the Risk of Atrial Fibrillation (from the REasons for Geographic And Racial Differences in Stroke [REGARDS] Study).  121:199-204. 2018
  • Comparison of Risk of Atrial Fibrillation Among Employed Versus Unemployed (from the REasons for Geographic and Racial Differences in Stroke Study).  120:1298-1301. 2017
  • Usefulness of Atrial Premature Complexes on Routine Electrocardiogram to Determine the Risk of Atrial Fibrillation (from the REGARDS Study).  120:782-785. 2017
  • Safety and Efficacy of Uninterrupted Apixaban Therapy Versus Warfarin During Atrial Fibrillation Ablation.  120:404-407. 2017
  • Relation Between Estimated Cardiorespiratory Fitness and Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).  119:1776-1780. 2017
  • High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).  118:1826-1830. 2016
  • Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.  118:232-236. 2016
  • Comparison of length of stay, 30-day mortality, and 30-day readmission rates in medicare patients with heart failure and with reduced versus preserved ejection fraction.  118:79-85. 2016
  • Infections, arrhythmias, and hospitalizations on home intravenous inotropic therapy.  117:952-956. 2016
  • Electrocardiographic Screening in National Collegiate Athletic Association Athletes.  118:754-759. 2016
  • Should Antihypertensive Treatment Recommendations Differ in Patients with and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]).  117:105-115. 2016
  • Effect of falls on frequency of atrial fibrillation and mortality risk (from the REasons for Geographic and Racial Differences in Stroke study).  116:1213-1218. 2015
  • Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.  115:447-453. 2015
  • Impact of gait speed and instrumental activities of daily living on all-cause mortality in adults ≤65 years with heart failure.  115:797-801. 2015
  • Relation between cancer and atrial fibrillation (from the reasons for geographic and racial differences in stroke study).  115:1090-1094. 2015
  • Reply.  115:156. 2015
  • Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event.  114:826-831. 2014
  • Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults.  114:909-913. 2014
  • Spironolactone use and higher hospital readmission for medicare beneficiaries with heart failure, left ventricular ejection fraction <45%, and estimated glomerular filtration rate <45 ml/min/1.73 m2.  114:79-82. 2014
  • Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and Mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the reasons for geographic and racial differences in stroke study).  113:1933-1940. 2014
  • Relation of left ventricular mass at age 23 to 35 years to global left ventricular systolic function 20 years later (from the Coronary Artery Risk Development in Young Adults Study).  113:377-383. 2014
  • Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event..  114:826-831. 2014
  • Impact of atrial fibrillation and heart failure, independent of each other and in combination, on mortality in community-dwelling older adults..  114:909-913. 2014
  • Outcomes of patients with ischemic mitral regurgitation undergoing percutaneous coronary intervention.  114:1011-1017. 2014
  • Relations between Depressive Symptoms, Anxiety, and T Wave Abnormalities in Subjects Without Clinically-Apparent Cardiovascular Disease (from the Multi-Ethnic Study of Atherosclerosis [MESA]).  114:1917-1922. 2014
  • Hemodynamic phenotype of the failing Fontan in an adult population.  112:1943-1947. 2013
  • Prevalence of troponin elevations in patients with cardiac arrest and implications for assessing quality of care in hypothermia centers.  112:933-937. 2013
  • Trends in the prevalence, awareness, treatment and control of high low density lipoprotein-cholesterol among United States adults from 1999-2000 Through 2009-2010.  112:664-670. 2013
  • Exercise stress tests for detecting myocardial ischemia in asymptomatic patients with diabetes mellitus.  112:14-20. 2013
  • Changes in cardiovascular risk associated with phentermine and topiramate extended-release in participants with comorbidities and a body mass index ≥27 kg/m2.  111:1131-1138. 2013
  • Takotsubo cardiomyopathy: Overrepresentation of cases.  111:922. 2013
  • Importance of three-dimensional geometric analysis in the assessment of the athlete's heart.  111:1067-1072. 2013
  • Implications of left bundle branch block in patient treatment.  111:291-300. 2013
  • Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.  111:190-195. 2013
  • Effect of ranolazine on left ventricular dyssynchrony in patients with coronary artery disease.  110:1440-1445. 2012
  • Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension.  110:1546-1550. 2012
  • Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the national registry of myocardial infarction).  110:1256-1261. 2012
  • Frequency of edema in patients with pulmonary arterial hypertension receiving ambrisentan.  110:1373-1377. 2012
  • United States National prevalence of electrocardiographic abnormalities in black and white middle-age (45- to 64-Year) and older (≥65-Year) adults (from the Reasons for Geographic and Racial Differences in Stroke Study).  109:1223-1228. 2012
  • Relations between QRS.  109:981-987. 2012
  • Effect of chest compressions on ventricular activation.  109:670-674. 2012
  • Effect of warfarin on outcomes in septuagenarian patients with atrial fibrillation.  109:370-377. 2012
  • A propensity-matched study of the association of diabetes mellitus with incident heart failure and mortality among community-dwelling older adults.  108:1747-1753. 2011
  • A propensity-matched study of the comparative effectiveness of angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors in heart failure patients age <65 years.  108:1443-1448. 2011
  • Predictors of low clopidogrel adherence following percutaneous coronary intervention.  108:822-827. 2011
  • Left ventricular diastolic function and exercise capacity in community-dwelling adults ≥65 years of age without heart failure.  108:735-740. 2011
  • Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study).  108:227-232. 2011
  • Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin.  107:1796-1801. 2011
  • Clustering of metabolic abnormalities among obese patients and mortality after percutaneous coronary intervention.  107:1415-1420. 2011
  • Relation between heart rate and left ventricular mechanical dyssynchrony in patients with end-stage renal disease.  107:1235-1240. 2011
  • Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure.  107:1208-1214. 2011
  • Sex, clinical symptoms, and angiographic findings in patients with diabetes mellitus and coronary artery disease (from the Bypass Angioplasty Revascularization Investigation [BARI] 2 Diabetes Trial).  107:980-985. 2011
  • Efficacy of fenofibric acid plus statins on multiple lipid parameters and its safety in women with mixed dyslipidemia.  107:898-905. 2011
  • Frequency of atrial flutter after adult lung transplantation.  107:922-926. 2011
  • Warfarin use and outcomes in patients with advanced chronic systolic heart failure without atrial fibrillation, prior thromboembolic events, or prosthetic valves.  107:552-557. 2011
  • Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up.  107:321-324. 2011
  • Effect of serum Insulin on the association between hyperuricemia and incident heart failure.  106:1134-1138. 2010
  • Left ventricular mechanical dyssynchrony by phase analysis of gated single photon emission computed tomography in end-stage renal disease.  106:1042-1047. 2010
  • Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (Insights from the BEST Trial).  106:221-227. 2010
  • Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data from the Treating to New Targets [TNT] Trial).  105:905-911. 2010
  • Blunting of the Heart Rate Response to Adenosine and Regadenoson in Relation to Hyperglycemia and the Metabolic Syndrome.  105:839-843. 2010
  • Effect of Intensive Lifestyle Changes on Endothelial Function and on Inflammatory Markers of Atherosclerosis.  105:362-367. 2010
  • Correlation Between Serum Cardiac Markers and Myocardial Infarct Size Quantified by Myocardial Perfusion Imaging in Patients With Hypertrophic Cardiomyopathy After Alcohol Septal Ablation.  105:261-266. 2010
  • Safety of Regadenoson in Patients with End-Stage Renal Disease.  105:133-135. 2010
  • Relation of Consistency With the Dietary Approaches to Stop Hypertension Diet and Incidence of Heart Failure in Men Aged 45 to 79 Years.  104:1416-1420. 2009
  • Electrocardiographic Screening in Children With Attention-Deficit Hyperactivity Disorder.  104:1296-1299. 2009
  • Value of Orthopnea, Paroxysmal Nocturnal Dyspnea, and Medications in Prospective Population Studies of Incident Heart Failure.  104:259-264. 2009
  • Drug-Eluting Stents in Heart Transplant Recipients.  103:1624-1625. 2009
  • Relation Between Heart Rate Response to Adenosine and Mortality in Patients With End-Stage Renal Disease.  103:1159-1164. 2009
  • A Propensity-Matched Study of Elevated Jugular Venous Pressure and Outcomes in Chronic Heart Failure.  103:839-844. 2009
  • The Editor's Roundtable: Advances in Myocardial Perfusion Imaging.  103:680-687. 2009
  • Usefulness of Three Posterior Chest Leads for the Detection of Posterior Wall Acute Myocardial Infarction.  103:159-164. 2009
  • A Propensity-Matched Study of the Association of Peripheral Arterial Disease With Cardiovascular Outcomes in Community-Dwelling Older Adults.  103:130-135. 2009
  • Multimorbidity Due to Diabetes Mellitus and Chronic Kidney Disease and Outcomes in Chronic Heart Failure.  103:88-92. 2009
  • Digoxin and Reduction of Heart Failure Hospitalization in Chronic Systolic and Diastolic Heart Failure.  102:1681-1686. 2008
  • Role of Myocardial Perfusion Imaging in Patients With End-Stage Renal Disease Undergoing Coronary Angiography.  102:1451-1456. 2008
  • Comparison of Effectiveness of Atorvastatin 10 mg Versus 80 mg in Reducing Major Cardiovascular Events and Repeat Revascularization in Patients With Previous Percutaneous Coronary Intervention (Post Hoc Analysis of the Treating to New Targets [TNT] Study).  102:1312-1317. 2008
  • Heart Rate Response to Adenosine in Patients With Diabetes Mellitus and Normal Myocardial Perfusion Imaging.  102:1103-1106. 2008
  • Prevalent Cocaine Use and Myocardial Infarction.  102:966-969. 2008
  • The Carotid Revascularization Endarterectomy, vs. Stenting Trial (CREST): Target Enrollment of 2500 Expected By Mid-2008.  102:5I-5I. 2008
  • Diabetes Mellitus, Hypothalamic Hypoestrogenemia, and Coronary Artery Disease in Premenopausal Women (from the National Heart, Lung, and Blood Institute Sponsored WISE Study).  102:150-154. 2008
  • A Propensity-Matched Study of Hypertension and Increased Stroke-Related Hospitalization in Chronic Heart Failure.  101:1772-1776. 2008
  • Serial Evaluations of Myocardial Infarct Size After Alcohol Septal Ablation in Hypertrophic Cardiomyopathy and Effects of the Changes on Clinical Status and Left Ventricular Outflow Pressure Gradients.  101:1328-1333. 2008
  • Predictors of Survival in Patients With End-Stage Renal Disease Evaluated for Kidney Transplantation.  100:1020-1025. 2007
  • Effect of Primary Mitral Regurgitation on Left Ventricular Synchrony.  100:707-711. 2007
  • The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): Rationale, Design, and Methods.  99. 2007
  • A New Generation of Coronary Vasodilators in Stress Perfusion Imaging.  99:1619-1620. 2007
  • Chronic Kidney Disease Associated Mortality in Diastolic Versus Systolic Heart Failure: A Propensity Matched Study†The Digitalis Investigation Group study was conducted and supported by the National Heart, Lung, and Blood Institute in collaboration with the Digitalis Investigation Group Investigators ....  99:393-398. 2007
  • Effectiveness and Safety of Glycoprotein IIb/IIIa Inhibitors and Clopidogrel Alone and in Combination in Non-ST-Segment Elevation Myocardial Infarction (from the National Registry of Myocardial Infarction-4).  98:1125-1131. 2006
  • Outcome of Patients With Adenosine-Induced ST-Segment Depression But With Normal Perfusion on Tomographic Imaging.  98:1009-1011. 2006
  • Meta-Analysis of Data from the Six Primary Prevention Trials of Cardiovascular Events Using Aspirin.  98:746-750. 2006
  • Plasma Atrial Natriuretic Peptide and Brain Natriuretic Peptide Levels After Radiofrequency Catheter Ablation of Atrial Fibrillation.  97:1741-1744. 2006
  • Association of Coronary Artery Calcified Plaque With Clinical Coronary Heart Disease in the National Heart, Lung, and Blood Institute's Family Heart Study.  97:1564-1569. 2006
  • Racial Differences in the Association of Coronary Calcified Plaque With Left Ventricular Hypertrophy: The National Heart, Lung, and Blood Institute Family Heart Study and Hypertension Genetic Epidemiology Network.  97:1441-1448. 2006
  • Usefulness of Esophageal Leads for Determining the Strategy of Pulmonary Vein Ablation to Avoid Complications Associated With the Esophagus.  97:1494-1497. 2006
  • Gastrointestinal Considerations in Patients with Cardiovascular Disease Using Nonopioid Analgesics for Mild-to-Moderate Pain or Cardioprotection.  97:17-22. 2006
  • Comparison of management of four patients with idiopathic dilated cardiomyopathy in a disease management program versus by a primary care physician.  97:253-255. 2006
  • Thirty-month outcome after fractional flow reserve-guided versus conventional multivessel percutaneous coronary intervention.  96:877-884. 2005
  • Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years.  96:83-88. 2005
  • Left ventricular function in patients with type 2 diabetes mellitus.  95:798-801. 2005
  • Artificial neural network modeling of stress single-photon emission computed tomographic imaging for detecting extensive coronary artery disease.  95:178-181. 2005
  • Relation between effects of adenosine on brachial artery reactivity and perfusion pattern in patients with known or suspected coronary artery disease.  95:304-307. 2005
  • Prevalence of diabetes mellitus and related conditions in Asian Indians living in the United States.  94:977-980. 2004
  • Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-Brachial Artery Reactivity study).  94:294-299. 2004
  • Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B.  94:219-222. 2004
  • Effect of caffeine administered intravenously on intracoronary- administered adenosine-induced coronary hemodynamics in patients with coronary artery disease.  93:343-346. 2004
  • Prevalence of stroke and associated risk factors in Asian Indians living in the state of Georgia, United States of America.  93:267-269. 2004
  • Coronary tracheal collaterals after heart-lung transplant.  92:1490-1492. 2003
  • Usefulness of preoperative stress perfusion imaging in predicting prognosis after liver transplantation.  92:1066-1071. 2003
  • Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation.  92:146-151. 2003
  • Effect of postmenopausal hormone therapy on coronary heart disease events after percutaneous transluminal coronary angioplasty.  91:989-991. 2003
  • Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III registry).  90:1154-1156. 2002
  • Safety and effectiveness of combined low molecular weight heparin and glycoprotein IIb/IIIa inhibitors.  90:911-915. 2002
  • Lipoprotein abnormalities related to women's health.  90:77-84. 2002
  • Lipoprotein abnormalities related to women's health..  90:77i-84i. 2002
  • Prognosis in the Thrombolysis in Myocardial Ischemia III Registry according to the Braunwald unstable angina pectoris classification.  90:821-826. 2002
  • Atypical presentations among medicare beneficiaries with unstable angina pectoris.  90:248-253. 2002
  • It's time to start treating obesity.  89:969-970. 2002
  • Blood pressure responses to acute stress and left ventricular mass (The Hypertension Genetic Epidemiology Network Study).  89:536-540. 2002
  • Efficacy of perindopril in the treatment of systemic hypertension..  88:3i-12i. 2001
  • Efficacy of perindopril in the treatment of systemic hypertension.  88:3-12. 2001
  • The American journal of cardiology: Introduction.  88. 2001
  • Troponin levels in patients with amyloid cardiomyopathy undergoing cardiac transplantation.  88:813-815. 2001
  • Enhancing recovery in coronary heart disease (ENRICHD): Baseline characteristics.  88:316-322. 2001
  • Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] study angiographic core laboratory).  87:937-941. 2001
  • Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.  87:721-726. 2001
  • Hypertension. Introduction..  88. 2001
  • Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (Benazepril) with calcium antagonist (Either Nifedipine or Amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.  86:1182-1187. 2000
  • Effect of angiotensin-converting enzyme inhibitor therapy on 30-day outcome in patients ≥65 years of age with chronic congestive heart failure.  86:1151-1153. 2000
  • Catheter ablation of atrial fibrillation: challenges and promise..  86:25K-27K. 2000
  • Effects of short-term estrogen treatment on the neointimal response to balloon injury of rat carotid artery.  85:1276-1279. 2000
  • Effect of coronary angiography on use of lipid-lowering agents in women: A report from the women's ischemia syndrome evaluation (WISE) study.  85:1083-1088. 2000
  • Quality of life after coronary revascularization in the United States and Canada.  85:548-553. 2000
  • Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2).  84:1287-1291. 1999
  • Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension..  84:35S-41S. 1999
  • Comparison of dobutamine echocardiography, dobutamine sestamibi, and rest-redistribution thallium-201 single-photon emission computed tomography for determining contractile reserve and myocardial ischemia in ischemic cardiomyopathy.  84:626-631. 1999
  • Effects of candesartan cilexetil in patients with severe systemic hypertension.  84:289-293. 1999
  • Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators..  84:289-293. 1999
  • Impact of stress single-photon emission computed tomography perfusion imaging on downstream resource utilization.  83:1401-1403. 1999
  • Anti-ischemic effects of Amlodipine in patients with stable angina pectoris and myocardial ischemia during daily life.  83:1117-1119. 1999
  • David Kempton Cartwright Cooper, MD: A conversation with the editor.  83:1253-1262. 1999
  • Comparison of the prognostic value of qualitative versus quantitative stress tomographic perfusion imaging.  83:945-948. 1999
  • Prognostic utility of myocardial viability assessment.  83:696-702. 1999
  • Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.  83:507-514. 1999
  • Lewis blood group phenotype as an independent risk factor for coronary heart disease (the NHLBI Family Heart Study).  83:345-348. 1999
  • Predictors of outcome of medically treated patients with left main/three-vessel coronary artery disease by coronary angiography.  83:445-448. 1999
  • Consensus recommendations for the management of chronic heart failure: Introduction.  83. 1999
  • Comparison of the polar maps method and the summed stress score for predicting outcome in medically treated patients with coronary artery disease.  83:258-259. 1999
  • Referral patterns to a university-based cardiac rehabilitation program.  83:252-255. 1999
  • Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension..  84:35-41. 1999
  • Comparison of outcomes research with clinical trials using preexisting data.  84:923-927. 1999
  • Consultation before thrombolytic therapy in acute myocardial infarction.  83:89-93. 1999
  • Management and outcomes for black patients with acute myocardial infarction in the reperfusion era.  82:1019-1023. 1998
  • Presenting characteristics, treatment patterns, and clinical outcomes of non-black minorities in the national registry of myocardial infarction 2.  82:1013-1018. 1998
  • Effects of Candesartan cilexetil in patients with systemic hypertension.  82:961-965. 1998
  • Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators..  82:961-965. 1998
  • Hemodynamic effects of arbutamine.  82:699-702. 1998
  • Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (the second national registry of myocardial infarction).  82:259-264. 1998
  • Efficacy of coronary stenting in the management of cardiac allograft vasculopathy.  82:239-241. 1998
  • Impact of exercise single-photon emission computed tomographic imaging on appropriateness of coronary revascularization.  81:1489-1491. 1998
  • Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris.  80:1546-1550. 1997
  • Utility of stress single-photon emission computed tomography (SPECT) perfusion imaging in predicting outcome after coronary artery bypass grafting.  80:1517-1521. 1997
  • Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (The Asymptomatic Cardiac Ischemia Pilot [ACIP] study).  80:1395-1401. 1997
  • Antihypertensive effects of mibefradil in the treatment of mild-to- moderate systemic hypertension.  80. 1997
  • Antihypertensive effects of mibefradil in the treatment of mild-to-moderate systemic hypertension..  80:12C-19C. 1997
  • The time course of left ventricular remodeling after acute myocardial infarction.  80:506-507. 1997
  • Usefulness of transesophageal echocardiography in the assessment of aortic graft dehiscence.  80:372-376. 1997
  • Usefulness of combined color Doppler/contrast in providing complete delineation of left ventricular cavity.  80:98-101. 1997
  • Myocardial perfusion imaging during adenosine-induced coronary hyperemia.  79:20-24. 1997
  • Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris.  79:1401-1405. 1997
  • Genetic haterogeneity of familial atrial myxoma syndromes (Carney complex).  79:994-995. 1997
  • Comparison of Multiplane and Biplane Transesophageal Echocardiography in the Assessment of Aortic Stenosis.  79:436-441. 1997
  • Cost and therapeutic modification of intracoronary ultrasound-assisted coronary angioplasty.  77:1278-1282. 1996
  • Relation of patient characteristics to cardiac ischemia during daily life activity (an Asymptomatic Cardiac Ischemia Pilot data bank study).  77:1267-1272. 1996
  • A randomized factorial trial of reperfusion strategies and aspirin dosing in acute myocardial infarction.  77:791-797. 1996
  • Prognosis of patients with severe left ventricular dysfunction after coronary artery bypass grafting..  77:199-200. 1996
  • Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry).  77:227-231. 1996
  • Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi.  78:562-564. 1996
  • The efficacy and safety of Pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl.  77:83-85. 1996
  • Treatment of hyperlipidemia after heart transplantation and rationale for the heart transplant lipid registry.  78:532-535. 1996
  • Use of calcium channel antagonists in myocardial revascularization procedures.  77:26D-31D. 1996
  • Acute hemodynamic effects of the prostacyclin analog 15AU81 in severe congestive heart failure.  75. 1995
  • Role of telemetry monitoring in the non-intensive care unit.  76:960-965. 1995
  • Efficacy of high-intensity exercise training on left ventricular ejection fraction in men with coronary artery disease (The Training Level Comparison Study).  76:643-647. 1995
  • Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the national registry of myocardial infarction).  76:548-552. 1995
  • Is quantification necessary in SPECT perfusion imaging?.  75:1175-1176. 1995
  • Comparison of the bruce and ramp protocols in the assessment of left ventricular performance during exercise in healthy women.  75:963-966. 1995
  • Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris.  75. 1995
  • Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy.  75:759-762. 1995
  • Optimizing patient selection for coronary angiography..  75:14D-17D. 1995
  • Bypass Angioplasty Revascularization Investigation (BARI): baseline clinical and angiographic data..  75:9C-17C. 1995
  • Myocardial perfusion pattern in patients with cocaine-induced chest pain.  75:396-398. 1995
  • Safety and efficacy of epoprostenol in patients with severe congestive heart failure.  75:34A-43A. 1995
  • Safety and efficacy of epoprostenol in patients with severe congestive heart failure. Epoprostenol Multicenter Research Group..  75:34A-43A. 1995
  • Bypass Angioplasty Revascularization Investigation (BARI): Baseline clinical and angiographic data.  75:C9-C17. 1995
  • Optimizing patient selection for coronary angiography.  75:D14-D17. 1995
  • Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease.  74:769-771. 1994
  • Coronary artery disease and coronary artery bypass grafting in diabetic patients aged ≥65 years (report from the Coronary Artery Surgery Study [CASS] registry).  74:334-339. 1994
  • Outcomes of patients hospitalized to a telemetry unit.  74:357-362. 1994
  • Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction.  74:111-118. 1994
  • Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris.  74:9-17. 1994
  • Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris.  73:1165-1168. 1994
  • Improved transesophageal echocardiographic assessment of significant proximal narrowing of the left anterior descending and left circumflex coronary arteries using echo contrast enhancement.  73:1131-1133. 1994
  • A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty.  73:835-839. 1994
  • Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction.  73:729-736. 1994
  • Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction.  73:444-449. 1994
  • Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris.  73:213-218. 1994
  • Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.  72:1249-1256. 1993
  • Prognostic implications of normal exercise SPECT thallium images in patients with strongly positive exercise electrocardiograms.  72:1201-1203. 1993
  • Is the site of maximal coronary artery narrowing the culprit for future myocardial infarction?.  72:861-862. 1993
  • Study of myocardial infarct remodeling by single-photon emission computed tomographic imaging.  72:747-752. 1993
  • Coronary arterial patterns in double-outlet right ventricle.  71:1108-1110. 1993
  • Rapid assessment of aortic regurgitation and left ventricular function using cine nuclear magnetic resonance imaging and the proximal convergence zone.  71:1074-1081. 1993
  • Usefulness of transesophageal echocardiography in the diagnosis of ventricular septal rupture secondary to acute myocardial infarction.  71:367-370. 1993
  • Operative results after unsuccessful radiofrequency ablation for Wolff-Parkinson-White syndrome.  70:1490-1491. 1992
  • What is the optimum dose of dipyridamole for cardiac imaging?.  70:1485-1486. 1992
  • Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men.  70:1051-1055. 1992
  • Frequency of stress-induced thallium-201 defects in patients with patent internal mammary artery to the left anterior descending coronary artery graft.  70:399-400. 1992
  • Mortality after coronary angioplasty and coronary artery bypass surgery (the national Medicare experience).  70:179-185. 1992
  • Mechanism off exercise-induced hypotension in coronary artery disease.  69:1517-1520. 1992
  • Evaluation of a prolonged infusion of recombinant tissue-type plasminogen activator (Duteplase) in preventing reocclusion following successful thrombolysis in acute myocardial infarction.  69:1120-1127. 1992
  • Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) II study.  69:1-9. 1992
  • Intravascular ultrasound imaging of saphenous vein graft stenosis.  69:133-136. 1992
  • Initial blood pressure response to enalapril in hospitalized patients (studies of left ventricular dysfunction [SOLVD]).  68:1465-1468. 1991
  • Dipyridamole sesta MIBI myocardial imaging.  68:674-675. 1991
  • Transesophageal echocardiographic assessment of congenital coronary artery to coronary sinus fistulas in adults.  68:263-266. 1991
  • Long-term effect of thrombolytic therapy on left ventricular ejection fraction after acute myocardial infarction.  67:1354-1359. 1991
  • Assessment of coronary artery disease using single-photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia.  67:1190-1194. 1991
  • Value and limitations of color doppler echocardiography in the evaluation of percutaneous balloon mitral valvuloplasty for isolated mitral stenosis.  67:1261-1267. 1991
  • Dipyridamole thallium imaging..  67:18D-26D. 1991
  • Clinical aspects of silent myocardial ischemia in China.  67:1146-1147. 1991
  • Uses and limitations of transthoracic echocardiography in the assessment of atrial septal defect in the adult.  67:288-294. 1991
  • Transesophageal echocardiography in critically III patients.  66:1492-1495. 1990
  • Left ventricular dilatation and pulmonary thallium uptake after single-photon emission computer tomography using thallium-201 during adenosine-induced coronary hyperemia.  66:807-811. 1990
  • Pacemaker therapy in congestive heart failure.  66:223-224. 1990
  • Utility of transesophageal echocardiography in interatrial septal puncture during percutaneous mitral balloon commissurotomy.  66:230-232. 1990
  • Combined use of transesophageal echocardiography and endocardial mapping to localize the site of origin of ectopic atrial tachycardia.  65:1284-1286. 1990
  • Heparin and infarct coronary artery patency after streptokinase in acute myocardial infarction.  65:967-972. 1990
  • Rapid method to determine the electrocardiographic frontal plane axis.  65:949-950. 1990
  • Coronary risk associated with age and sex of parental heart disease in the Framingham Study.  64:555-559. 1989
  • Use of technetium-99m isonitrile (RP-30A) in assessing left ventricular perfusion and function at rest and during exercise in coronary artery disease, and comparison with coronary arteriography and exercise thallium-201 SPECT imaging.  64:270-275. 1989
  • Effects of dilevalol, metoprolol and atenolol on left ventricular mass and function in nonelderly and elderly hypertensive patients.  63. 1989
  • Influence of beta2 agonism and beta1 and beta2 antagonism on adverse effects and plasma lipoproteins: Results of a multicenter comparison of dilevalol and metoprolol.  63. 1989
  • Two-dimensional and color Doppler assessment of ventricular septal defect of congenital origin.  63:1112-1116. 1989
  • Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study.  63:503-512. 1989
  • Differences in effects of aerobic exercise training on blood lipids in men and women.  63:254-256. 1989
  • Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris.  62:518-522. 1988
  • Angiographic demonstration of spasm in a left internal mammary artery used as a bypass to the left anterior descending coronary artery.  61:1363. 1988
  • Comparison of effects of medical and surgical therapy on survival in severe angina pectoris and two-vessel coronary artery disease with and without left ventricular dysfunction: A coronary artery surgery study registry study.  61:1198-1203. 1988
  • Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease.  61:269-272. 1988
  • Effect of intravenous isosorbide dinitrate versus nitroglycerin on elevated pulmonary arterial wedge pressure during acute myocardial infarction.  61:21-25. 1988
  • Relation of results of exercise stress tests in young women to phases of the menstrual cycle.  61:197-199. 1988
  • Factors affecting exercise left ventricular performance in patients free of obstructive coronary artery disease.  60:1173-1176. 1987
  • Color Doppler assessment of mitral regurgitation induced by supine exercise in patients with coronary artery disease.  59:1266-1270. 1987
  • Association of atrial flutter with orthodromic reciprocating fetal tachycardia.  59:374-375. 1987
  • Diagnosis of rupture of the ventricular septum during acute myocardial infarction by doppler color flow mapping.  59:162-163. 1987
  • Mitral valve myxoma diagnosed by two-dimensional echocardiography.  59:182-183. 1987
  • Age- and gender-related changes in exercise left ventricular function in mitral valve prolapse.  58:117-120. 1986
  • Identification of anomalous origin of the right coronary artery from pulmonary trunk by Doppler color flow mapping.  57:366-367. 1986
  • Collateral flow in patients with acute myocardial infarction.  56:729-736. 1985
  • Evaluation of aortic dissection by doppler color flow mapping.  56:497-498. 1985
  • Effects of intravenous infusion of esmolol and propranolol on biventricular performance at rest and during exercise as assessed by quantitative radionuclide angiography.  55:1287-1292. 1985
  • Improved myocardial contractility with glucose-insulin-potassium infusion during pacing in coronary artery disease.  55:932-936. 1985
  • Limitations of fluorocarbons in reducing myocardial infarct size.  55:830-834. 1985
  • Relation of body habitus to the severity of mitral stenosis in women.  55:857-859. 1985
  • Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.  55:696-702. 1985
  • Chronic traumatic thoracic aneurysm: Demonstration by two-dimensional echocardiography.  54:692-693. 1984
  • Congenital pulmonary vein stenosis.  54:369-375. 1984
  • Two-dimensional and doppler echocardiographic evaluation of aortic aneurysm and dissection.  54:379-385. 1984
  • Pulmonary artery aneurysms: echocardiographic features in 5 patients.  53:1438-1441. 1984
  • Two-dimensional echocardiographic diagnosis of mediastinal hematoma causing cardiac tamponade.  53:974-976. 1984
  • Elevated catecholamines during cardiac surgery: Consequences of reperfusion of the postarrested heart.  53:722-728. 1984
  • Evaluation of a QRS scoring system for estimating myocardial infarct size. IV. Correlation with quantitative anatomic findings for posterolateral infarcts.  53:706-714. 1984
  • Fetal doppler echocardiography: Methods and characterization of normal and abnormal hemodynamics.  53:572-578. 1984
  • Reduction of myocardial infarct size by a fluorocarbon-oxygenated reperfusate.  53:608-613. 1984
  • Doppler echocardiographic measurement of cardiac output: Comparison with a non-golden standard.  53:257-259. 1984
  • Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmias.  52:992-995. 1983
  • Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction.  52:965-968. 1983
  • Two-dimensional echocardiographic identification of aortico-left ventricular tunnel.  52:913-914. 1983
  • Biventricular function in sickle-cell anemia: Radionuclide angiographic and thallium-201 scintigraphic evaluation.  52:584-587. 1983
  • Obstruction within the right ventricular body: Two-dimensional echocardiographic features.  51:1498-1501. 1983
  • Reply.  51:1566. 1983
  • Enhancement of left ventricular function by glucose-insulin-potassium in acute myocardial infarction.  51:1041. 1983
  • Myocardial texture characterization by two-dimensional echocardiography.  51:817-825. 1983
  • Cryosurgery for cardiac arrhythmias: Acute and chronic effects on coronary arteries.  51:149-155. 1983
  • Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts.  51:382-389. 1983
  • Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction..  49:811-820. 1982
  • Advantages of the caudocranial left anterior oblique left ventriculogram in adult heart disease.  49:369-380. 1982
  • Beneficial effects of nifedipine on cardiac metabolism and function after cardioplegic arrest. A phosphorus-31 nuclear magnetic resonance study.  49:1023. 1982
  • Effects of cardioplegic infusion rate and topical hypothermia on elective cardiac arrest.  49:894. 1982
  • Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts.  49:1604-1614. 1982
  • Pulmonary valve echogram.  49:1085-1086. 1982
  • Total occlusion of the left main coronary artery: The Coronary Artery Surgery Study (CASS) experience.  49:2003-2010. 1982
  • Two-dimensional echocardiographic identification of pulmonary artery branch stenosis.  50:814-820. 1982
  • Advantage of the cranial-right anterior oblique view in diagnosing mid left anterior descending and distal right coronary artery disease.  48:754-764. 1981
  • Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the collaborative study in coronary artery surgery (CASS).  48:765-777. 1981
  • Method for quantitative analysis of regional left ventricular function with first pass and gated blood pool scintigraphy.  47:618-625. 1981
  • Two dimensional echocardiographic evaluation of exercise-induced left and right ventricular asynergy: Correlation with thallium scanning.  48:720-727. 1981
  • Unstable angina pectoris: National cooperative study group to compare medical and surgical therapy. IV. Results in patients with left anterior descending coronary artery disease.  48:517-524. 1981
  • Diabetic neuropathy of the heart and arteries.  45:475. 1980
  • Differentiation of left ventricular pseudoaneurysm from true aneurysm with two dimensional echocardiography.  46:869-878. 1980
  • Pathogenesis of paroxysmal hypertension developing during and after coronary bypass surgery: A study of hemodynamic and humoral factors.  46:559-565. 1980
  • Preservation of ischemic myocardium with glucose-insulin-potassium in patients with isolated left anterior descending stenosis.  45:484. 1980
  • Reply.  46:178. 1980
  • Surgical versus medical therapy for treatment of unstable angina: Changes in work status and family income.  45:134-140. 1980
  • Transient electrocardiographic changes in patients with unstable angina: Relation to coronary arterial anatomy.  46:28-33. 1980
  • Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy. III. Results in patients with S-T segment elevation during pain.  45:819-824. 1980
  • Hypertrophy in the denervated heart: A comparison of central sympatholytic treatment with 6-hydroxydopamine and peripheral sympathectomy with nerve growth factor antiserum.  44:970-978. 1979
  • Emergency revascularization for acute myocardial infarction: An unproved experimental approach.  44:1407-1409. 1979
  • Incidence of new pulmonary perfusion defects after routine cardiac catheterization.  43:529-532. 1979
  • Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction. Effects on myocardial hemodynamics, substrates and rhythm.  43:801-809. 1979
  • Quantitative coronary arteriography. Coronary anatomy of patients with unstable angina pectoris reexamined 1 year after optimal medical therapy.  43:699-707. 1979
  • Unstable angina pectoris: A comparison of the costs of medical and surgical treatment.  44:112-117. 1979
  • Relation of graded exercise test findings after myocardial infarction to extent of coronary artery disease and left ventricular dysfunction.  42:716-723. 1978
  • Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy. II. In-Hospital experience and initial follow-up results in patients with one, two and three vessel disease.  42:839-848. 1978
  • Acute effects of glucose-insulin-potassium infusion on myocardial substrates, coronary blood flow and oxygen consumption in man.  40:421-428. 1977
  • Coronary arterial surgery in patients with incapacitating angina pectoris and myxedema.  40:226-231. 1977
  • Echocardiographic features of right ventricular outflow tumor prolapsing into the pulmonary artery.  40:272-276. 1977
  • Effect of heparin-induced free fatty acid elevation on myocardial oxygen consumption in man.  40:365-372. 1977
  • Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease.  36:929-937. 1975
  • Effects of glucose-insulin-potassium on myocardial substrate availability and utilization in stable coronary artery disease. Studies on myocardial carbohydrate, lipid and oxygen arterial-coronary sinus differences in patients with coronary artery disease.  36:929-937. 1975
  • Thrombogenicity of guide wires.  32:943-946. 1973
  • Hypertrophic obstructive cardiomyopathy and Friedreich's ataxia.  28:496. 1971
  • International Standard Serial Number (issn)

  • 0002-9149
  • Electronic International Standard Serial Number (eissn)

  • 1879-1913